Comparing EMG-Biofeedback and Rebound Therapy for Endometriosis Relief
Official title: Comparison of the Effectiveness of EMG-Biofeedback and Rebound Therapy in Patients With Endometriosis
Run by Medipol University · NCT06517654 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing whether EMG-Biofeedback or Rebound Therapy can help women with endometriosis feel better and manage their symptoms more effectively.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years to 50 Years |
| Sex | Women only |
| Enrollment | 42 (estimated) |
| Sponsor | Medipol University Academic / other |
| Locations | 1 site (Üsküdar, İstanbul) |
| Trial ID | NCT06517654 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 20-50 diagnosed with endometriosis and experiencing moderate to severe pain.
✕Probably not a fit
Patients currently receiving medical treatment for endometriosis or those with certain medical conditions affecting their participation may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of two different pelvic floor muscle strengthening approaches—EMG-Biofeedback and Rebound Therapy—on women diagnosed with endometriosis. Participants will be divided into three groups: one receiving EMG-Biofeedback, another undergoing Rebound Therapy, and a third performing home exercises. Over an 8-week period, various assessments will be conducted to evaluate pelvic floor muscle strength, pain levels, perceived stress, quality of life, and sleep quality. The study aims to provide insights into which method may offer better relief for endometriosis symptoms.
Why it matters
Potential benefit: If successful, this study could provide effective non-pharmacological treatment options for women suffering from endometriosis.
How similar studies have gone: While there is ongoing research in this area, the specific comparison of EMG-Biofeedback and Rebound Therapy for endometriosis is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Being between 20-50 years old, * Being diagnosed with endometriosis, * Completing the voluntary consent form, * Pain level being at least 4 on the Visual Analog Scale (VAS). Exclusion Criteria: Exclusion Criteria for the EMG-Biofeedback Group: * Being included in another study during the study period, * Being receiving medical treatment for endometriosis, * Presence of gynecological bleeding, * Presence of communication and cooperation problems, * Presence of tubo-ovarian abscess, * Active vaginal or urinary tract infection, * Pregnancy and giving birth within the last 12 months, * Presence of impaired somatosensory status, * Not attending 2 consecutive sessions. Exclusion Criteria for the Rebound Therapy Group: In addition to the exclusion criteria determined for the EMG-Biofeedback Group; * Presence of a neurological or orthopedic disease affecting the lower extremity, * History of spine and/or lower extremity orthopedic surgery, * Presence of severe arthritis affecting the spine and/or lower extremity, * Presence of uncontrolled hypertension and cardiovascular disease.
Where it's running
-
Zeynep Kamil Women and Children's Diseases Training and Research Hospital
Üsküdar, İstanbul, Turkey Recruiting
Study contacts
- Study coordinator: Çağla Özgören, Msc
- Email: cagla.ozgoren@medipol.edu.tr
- Phone: 5316267328
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing different techniques to treat endometriosis
This study is testing different methods to treat endometriosis, like laser and heat techniques, to see which one works best for relieving pain in women who are already having surgery for the condition.
-
Postoperative Pain Trajectories After Endometriosis Surgery
This study tests how pain changes after endometriosis surgery and whether perioperative pain testing can predict who will have ongoing pain.
-
Imaging endometriosis with a special PET tracer in adult women
This study tests whether a PET/CT scan using [18F]AlF-FAPI-74 can help detect endometriosis lesions in women who are planning laparoscopy.
-
Fiber supplement for digestive symptoms in endometriosis
A fiber-based supplement is being tested to see if it is safe and helps with gut and vaginal microbiomes and digestive symptoms in women with endometriosis.
-
Stellate ganglion block and dexmedetomidine for better sleep after gynecologic laparoscopy
The study tests whether giving a preoperative stellate ganglion block plus intraoperative dexmedetomidine improves sleep after laparoscopic gynecologic surgery in women.
-
Atypical Endometriosis: Histology, Immunophenotype and Molecular Features
Researchers will look at how endometriotic tissue that looks atypical under the microscope relates to clinical features and ultrasound findings to better separate benign from potentially atypical lesions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.